单相抑郁患者与健康对照的脑脊液生物标志物:系统综述与Meta分析
该系统综述与Meta分析检索多个数据库至2021年8月25日,纳入97项研究、165种脑脊液生物标志物,其中42种有2项及以上研究量化。与健康对照相比,单相抑郁患者白介素6、总蛋白和皮质醇升高,高香草酸、γ-氨基丁酸、生长抑素、脑源性神经营养因子、淀粉样β40和转甲状腺素蛋白降低。
要点
- 单相抑郁患者脑脊液白介素6、总蛋白和皮质醇较健康对照升高。
- 高香草酸、γ-氨基丁酸、生长抑素、脑源性神经营养因子、淀粉样β40和转甲状腺素蛋白较健康对照降低。
- 其余33种生物标志物结果无统计学显著差异。
核心结论
- 单相抑郁患者脑脊液白介素6、总蛋白和皮质醇较健康对照升高,高香草酸、γ-氨基丁酸、生长抑素、脑源性神经营养因子、淀粉样β40和转甲状腺素蛋白较健康对照降低。
- 其余33种生物标志物结果无统计学显著差异。
- 作者认为这些发现指向多巴胺能系统失调、抑制系统受损、下丘脑-垂体-肾上腺轴过度活跃、神经炎症和血脑屏障通透性增加以及神经可塑性受损是抑郁病理生理的重要因素。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、EMBASE、PsycINFO、Cochrane Library、Web of Science和ClinicalTrials.gov从建库至2021年8月25日。
- 纳入研究为18岁及以上单相抑郁患者与健康对照的脑脊液生物标志物研究。
- 167项研究符合入选标准,其中97项有可用数据并纳入Meta分析,涵盖165种生物标志物,42种有2项及以上研究量化。
- 由2名评价者按照PRISMA和MOOSE报告指南进行数据提取和质量评估,采用随机效应模型计算标准化均数差(SMD)。
主要发现
- 单相抑郁患者较健康对照升高的标志物:白介素6(7项研究;SMD 0.35;95%CI 0.12至0.59;I²=16%)、总蛋白(5项研究;SMD 0.53;95%CI 0.35至0.72;I²=0%)、皮质醇(2项研究;SMD 1.23;95%CI 0.89至1.57;I²=0%)。
- 单相抑郁患者较健康对照降低的标志物:高香草酸(17项研究;SMD -0.26;95%CI -0.39至-0.14;I²=11%)、γ-氨基丁酸(4项研究;SMD -0.50;95%CI -0.92至-0.08;I²=55%)、生长抑素(5项研究;SMD -1.49;95%CI -2.53至-0.45;I²=91%)、脑源性神经营养因子(3项研究;SMD -0.58;95%CI -0.97至-0.19;I²=0%)、淀粉样β40(3项研究;SMD -0.80;95%CI -1.14至-0.46;I²=0%)、转甲状腺素蛋白(2项研究;SMD -0.82;95%CI -1.37至-0.27;I²=0%)。
- 其余33种生物标志物结果无统计学显著差异。
关键数值与推荐
- 共97项研究纳入Meta分析,涵盖165种生物标志物,其中42种在2项及以上研究中量化。
- 白介素6:7项研究,SMD 0.35,95%CI 0.12至0.59,I²=16%。
- 总蛋白:5项研究,SMD 0.53,95%CI 0.35至0.72,I²=0%。
- 皮质醇:2项研究,SMD 1.23,95%CI 0.89至1.57,I²=0%。
- 高香草酸:17项研究,SMD -0.26,95%CI -0.39至-0.14,I²=11%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Depression has been associated with alterations in neurotransmitters, hormones, and inflammatory and neurodegenerative biomarkers, and biomarkers quantified in the cerebrospinal fluid (CSF) are more likely to reflect ongoing biochemical changes within the brain. However, a comprehensive overview of CSF biomarkers is lacking and could contribute to the pathophysiological understanding of depression. OBJECTIVE: To investigate differences in quantified CSF biomarkers in patients with unipolar depression compared with healthy control individuals. DATA SOURCES: PubMed, EMBASE, PsycINFO, Cochrane Library, Web of Science, and ClinicalTrials.gov were searched for eligible trials from database inception to August 25, 2021. STUDY SELECTION: All studies investigating CSF biomarkers in individuals 18 years and older with unipolar depression and healthy control individuals were included. One author screened titles and abstracts, and 2 independent reviewers examined full-text reports. Studies that did not include healthy control individuals or included control individuals with recent hospital contacts or admissions that might affect CSF biomarker concentrations were excluded. DATA EXTRACTION AND SYNTHESIS: Data extraction and quality assessment were performed by 2 reviewers following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and Meta-analysis of Observational Studies in Epidemiology (MOOSE) reporting guidelines. Meta-analyses were performed using standardized mean differences (SMDs) calculated with random-effects models. A third investigator was consulted if the 2 reviewers reached different decisions or when in doubt. MAIN OUTCOMES AND MEASURES: Quantifiable CSF biomarkers. RESULTS: A total of 167 studies met eligibility criteria, and 97 had available data and were included in the meta-analysis. These 97 studies comprised 165 biomarkers, 42 of which were quantified in 2 or more studies. CSF levels of interleukin 6 (7 studies; SMD, 0.35; 95% CI, 0.12 to 0.59; I2 = 16%), total protein (5 studies; SMD, 0.53; 95% CI, 0.35 to 0.72; I2 = 0%), and cortisol (2 studies; SMD, 1.23; 95% CI, 0.89 to 1.57; I2 = 0%) were higher in patients with unipolar depression compared with healthy control individuals, whereas homovanillic acid (17 studies; SMD, -0.26; 95% CI, -0.39 to -0.14; I2 = 11%), γ-aminobutyric acid (4 studies; SMD, -0.50; 95% CI, -0.92 to -0.08; I2 = 55%), somatostatin (5 studies; SMD, -1.49; 95% CI, -2.53 to -0.45; I2 = 91%), brain-derived neurotrophic factor (3 studies; SMD, -0.58; 95% CI, -0.97 to -0.19; I2 = 0%), amyloid-β 40 (3 studies; SMD, -0.80; 95% CI, -1.14 to -0.46; I2 = 0%), and transthyretin (2 studies; SMD, -0.82; 95% CI, -1.37 to -0.27; I2 = 0%) were lower. The remaining 33 biomarkers had nonsignificant results. CONCLUSIONS AND RELEVANCE: The findings of this systematic review and meta-analysis point toward a dysregulated dopaminergic system, a compromised inhibitory system, hypothalamic-pituitary-adrenal axis hyperactivity, increased neuroinflammation and blood-brain barrier permeability, and impaired neuroplasticity as important factors in depression pathophysiology.
引用
- Mousten IV, Sørensen NV, Christensen RHB, et al. Cerebrospinal Fluid Biomarkers in Patients With Unipolar Depression Compared With Healthy Control Individuals: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2022. PMID: 35442429. doi:10.1001/jamapsychiatry.2022.0645
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。